Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3032641	u-aminoh	— (—)	85	107	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Mental retardation, excluding more controls

27.87

14.92

1.0

1.1

—

Care involving use of rehabilitation procedures

6.24

14.37

1.3

1.2

—

All kidney diseases

4.98

13.09

1.5

1.2

—

Other disorders of amino-acid metabolism

+∞

11.58

2.4

0.0

—

Persons encountering health services for specific procedures and health care

4.36

11.45

1.4

1.2

—

Calculus of kidney and ureter

21.45

10.66

1.2

1.3

—

Mixed specific developmental disorders

9.42

10.44

1.0

1.3

—

Mental retardation, wide definition

9.15

10.44

1.0

1.4

—

Mental retardation

9.15

10.44

1.0

1.4

—

Urolithiasis

16.68

9.85

1.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

4.29

9.63

1.3

—

Metabolic disorders

4.59

9.36

1.7

1.1

—

All chronic kidney diseases

4.78

8.85

1.7

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.36

8.59

1.1

1.2

—

Intestinal infectious diseases

3.72

8.19

1.3

—

Procreative management

4.33

7.98

1.3

1.2

—

Speech and linguistic disorders

4.68

7.85

1.1

1.2

—

Hyperkinetic disorders, excluding more controls

10.90

7.71

1.3

1.1

—

Other and unspecified mental retardation

10.10

7.51

1.0

1.4

—

Any mental disorder

5.30

6.93

1.2

1.4

—

Renal tubulo-interstitial diseases

3.94

6.88

1.7

1.2

—

Speech and linguistic disorders, excluding more controls

11.28

6.79

1.1

—

Epilepsy

6.06

6.73

1.1

1.2

—

Disorders of amino-acid transport

+∞

6.34

2.3

0.0

—

Convulsions, not elsewhere classified

8.03

6.26

1.2

1.3

—

Malaise and fatigue

6.89

5.88

1.3

—

Psychiatric diseases

5.01

5.86

1.3

1.4

—

Implicit viral Sepsis

9.17

5.78

1.3

—

Viral Sepsis

9.17

5.78

1.3

1.2

—

Other functional intestinal disorders

3.63

5.67

1.2

—

Other viral diseases, including avohilmo

3.36

5.48

1.4

1.2

—

Disorders of psychological development

4.95

5.44

1.1

1.3

—

Chronic kidney disease

8.14

5.40

1.9

1.2

—

Medical observation and evaluation for suspected diseases and conditions

4.79

5.32

1.1

1.2

—

Other disorders of fluid, electrolyte and acid-base balance

15.07

5.23

1.6

1.0

—

Provisional assignment of new diseases of uncertain etiology

4.96

5.19

1.3

—

Codes for special purposes

4.96

5.19

1.3

—

Dental caries

6.66

5.19

1.8

1.1

—

Anaemias

5.34

5.08

1.4

1.0

—

Endocrine, nutritional and metabolic diseases

3.27

4.97

1.3

1.1

—

Delayed milestone in childhood

4.43

4.91

1.0

1.3

—

Cerebral palsy

11.55

4.79

1.0

1.4

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3.00

4.76

1.4

1.3

—

Implicit Sepsis

3.81

4.75

1.2

1.1

—

Diseases of oesophagus, stomach and duodenum

3.30

4.62

1.2

1.5

—

Disorders of other endocrine glands

3.22

4.60

1.4

1.2

—

Specific development disorders of speech and language

5.52

4.60

1.2

1.4

—

All influenza

5.46

4.59

1.5

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.91

4.59

1.4

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

3.54

4.59

1.3

—

Care involving dialysis

14.02

4.57

2.3

1.2

—

Cerebral palsy and other paralytic syndromes

8.19

4.55

1.0

1.4

—

Episodal and paroxysmal disorders

2.75

4.52

1.2

—

Fever of other and unknown origin

4.89

4.44

1.5

1.2

—

Covid-19 confirmed case

5.78

4.43

1.2

1.3

—

ILD medications: immunosuppressive drugs

3.29

4.40

1.4

1.2

—

Constipation

2.94

4.28

1.3

1.2

—

Hyperkinetic disorders

3.33

4.27

1.3

1.2

—

Implicit viral Sepsis, including avohilmo

5.49

4.27

1.3

1.2

—

Acute tubulo-interstitial nephritis

3.95

4.19

1.7

1.2

—

Type 2 diabetes, strict (exclude DM1)

8.72

4.17

1.9

1.2

—

Influenza and pneumonia

2.64

4.16

1.5

1.2

—

Astigmatism

6.93

4.15

1.0

1.3

—

Type 2 diabetes, definitions combined, including avohilmo

8.67

4.15

1.9

1.2

—

Implicit Sepsis, including avohilmo

3.26

4.09

1.2

1.1

—

Any gastric operation

2.93

4.06

1.2

—

GASTRO-related operations

2.93

4.06

1.2

—

Dialysis, with operation codes

8.01

4.06

2.1

1.3

—

Gastro-oesophageal reflux disease

4.38

4.05

1.1

1.4

—

Congenital malformations of the nervous system

10.06

4.01

1.1

1.6

—

Renal failure

5.20

4.01

1.9

1.2

—

Transplanted organ and tissue status

6.44

3.98

1.4

1.1

—

Acute sinusitis

5.00

3.93

1.3

1.5

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2.96

3.90

1.2

—

Type 2 diabetes, definitions combined

7.48

3.87

1.9

1.1

—

Pain, not elsewhere classified

7.28

3.85

1.1

1.3

—

Nausea and vomiting

3.96

3.79

1.2

1.1

—

Disturbance of activity and attention

3.70

3.78

1.2

—

Mild mental retardation

8.80

3.77

1.0

1.4

—

Symptoms and signs involving the urinary system

3.77

3.71

1.4

1.2

—

Pneumonia, organism unspecified

2.69

3.71

1.5

1.2

—

Anxiety disorders, excluding more controls

5.02

3.70

1.2

1.4

—

Acute pharyngitis

4.54

3.70

1.1

1.2

—

Other and unspecified anaemias

6.83

3.68

1.5

1.2

—

Other anaemias

6.80

3.67

1.5

1.2

—

Motor disorders, excluding more controls

8.28

3.62

1.0

1.1

—

Benzodiazepine use

3.16

3.61

1.1

1.5

—

Hypertension, essential

5.65

3.60

1.5

1.2

—

Hypoglycaemia, other or unspecified

7.79

3.56

1.0

1.3

—

Other disorders of glucose regulation and pancreatic internal secretion

7.79

3.55

1.0

1.3

—

Birth asphyxia

10.25

3.52

1.0

1.3

—

Glomerular diseases

6.16

3.50

1.3

—

Other diseases of the respiratory system

10.00

3.49

1.3

1.2

—

Other respiratory disorders and diseases

10.00

3.49

1.3

1.2

—

Headache

4.03

3.47

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.78

3.45

1.1

1.2

—

Implicit bacterial Sepsis

6.23

3.43

1.3

1.2

—

Implicit bacterial Sepsis, including avohilmo

6.05

3.35

1.3

1.2

—

Neurological diseases

2.51

3.31

1.1

1.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.84

3.29

1.2

—

Specific developmental disorder of motor function

5.61

3.27

1.0

1.4

—

Unspecified haematuria

7.12

3.27

1.6

1.1

—

Other disorders starting during childhood or adolecense, excluding more controls

6.69

3.25

1.3

1.1

—

Used for control exclusion in common control thyroid runs

2.37

3.24

1.2

—

Nonsuppurative otitis media

3.42

3.24

1.5

1.2

—

Open bite

4.75

3.23

1.3

—

Other symptoms and signs involving cognitive functions and awareness

8.86

3.23

1.3

1.5

—

Other viral diseases

2.77

3.22

1.3

1.2

—

Viral and other specified intestinal infections

3.55

3.19

1.4

1.1

—

Kidney transplant status

6.38

3.18

1.6

1.2

—

Iron deficiency anaemia

4.65

3.17

1.2

1.3

—

Infections, IBD-co-morbidities

7.03

3.14

1.6

1.1

—

Other and unspecified tonsillitis

3.56

3.14

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

3.25

3.13

1.2

—

Aplastic and other anaemias

5.23

3.10

1.5

1.2

—

Nutritional anaemias

4.51

3.09

1.2

1.3

—

Caries of dentine

5.14

3.09

1.3

1.1

—

Viral and other specified intestinal infections, including avohilmo

3.21

3.07

1.4

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2.37

3.07

1.5

1.2

—

Other and unspecified iron deficiency

4.99

3.04

1.3

1.4

—

Other disorders of urethra and urinary system

3.83

3.03

1.5

1.4

—

Nephropathy related operations

5.84

3.02

2.0

1.2

—

Wide developmental disorders, excluding more controls

7.34

3.00

1.0

—

Hypertensive diseases (excluding secondary)

3.15

2.99

1.5

1.3

—

Extracorporeal dialysis

10.02

2.98

2.4

1.2

—

Examination and observation for other reasons

3.88

2.95

1.0

1.2

—

Persons encountering health services in other circumstances

3.51

2.95

1.3

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

2.32

2.94

1.5

1.2

—

All influenza (not pneumonia)

4.71

2.91

1.5

1.1

—

Substance abuse, excluding more controls

7.16

2.88

1.5

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3.04

2.85

1.7

1.2

—

3.04

2.85

1.7

1.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4.64

2.82

1.8

1.1

—

Bacterial Sepsis

4.13

2.82

1.2

1.1

—

Use of hypnotics and sedatives

2.76

2.81

1.3

1.4

—

All pneumoniae

2.27

2.81

1.5

1.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3.57

2.78

1.3

1.2

—

Genitourinary diseases

2.44

2.75

1.2

1.1

—

Other inflammation of eyelid

8.34

2.75

1.2

1.7

—

Other bacterial intestinal infections, including avohilmo

8.34

2.75

1.0

1.2

—

Obsessive-compulsive disorder

8.34

2.75

1.2

—

Any death

6.99

2.74

1.5

1.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.30

2.72

1.3

—

Lack of expected normal physiological development

5.13

2.71

1.0

1.2

—

Other viral diseases, not elsewhere classified

2.78

2.62

1.0

1.2

—

Type 2 diabetes

4.63

2.62

1.9

1.4

—

Complications of medical and surgical care

3.67

2.58

1.7

1.4

—

Other disorders originating in the perinatal period

4.06

2.58

1.0

1.3

—

Bleeding

3.00

2.56

1.6

1.2

—

Specific development disorders of scholastic skills

4.58

2.55

1.0

1.5

—

Visual impairment including blindness (binocular or monocular)

7.15

2.55

1.0

1.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.57

2.55

1.6

1.1

—

All anxiety disorders

2.82

2.54

1.5

1.3

—

Purpura and other haemorrhagic conditions

5.46

2.54

1.3

1.2

—

Nonsuppurative otitis media, including avohilmo

3.07

2.52

1.5

1.2

—

Pervasive developmental disorders excl. Autism + Asperger

5.43

2.52

1.0

1.5

—

Neurotic, stress-related and somatoform disorders

2.71

2.50

1.2

1.3

—

Explicit Sepsis

3.25

2.50

1.2

—

Other viral diseases, not elsewhere classified, including avohilmo

2.58

2.49

1.0

1.2

—

Explicit Sepsis, including avohilmo

3.24

2.49

1.2

—

Anxiety disorders

2.70

2.48

1.2

1.3

—

Focal epilepsy, strict definition

3.81

2.46

1.1

1.2

—

Intestinal infectious diseases, including avohilmo, including avohilmo

2.25

2.42

1.3

—

Acute laryngitis and tracheitis

3.75

2.42

1.0

1.2

—

Bronchitis

2.50

2.41

1.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.64

2.39

1.3

1.2

—

Other chromosome abnormalities, not elsewhere classified

6.39

2.38

1.0

1.4

—

Hypertension

2.71

2.37

1.5

1.2

—

Statin medication

4.09

2.37

1.5

—

Focal epilepsy

3.64

2.36

1.1

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.11

2.35

1.6

1.2

—

Other problems related to primary support group, including family circumstances

2.82

2.32

1.4

1.2

—

Abnormal findings on examination of blood, without diagnosis

3.62

2.32

1.8

1.2

—

Abnormal serum enzyme levels

6.03

2.31

1.6

1.3

—

Other endocrine disorders

2.78

2.28

1.4

1.2

—

Urticaria and erythema

2.75

2.27

1.5

1.2

—

L04AD Calcineurin inhibitors

3.48

2.27

1.5

1.2

—

Other reaction to severe stress, and adjustment disorders

3.89

2.25

1.4

1.3

—

Hypertensive diseases

2.62

2.24

1.5

1.3

—

Autoimmune diseases excluding thyroid diseases

2.12

2.24

1.4

1.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

5.97

2.24

1.8

1.6

—

Follow-up examination after treatment for conditions other than malignant neoplasms

4.99

2.23

1.2

1.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.17

2.22

1.2

—

Complications of surgical and medical care, not elsewhere classified

2.82

2.22

1.5

1.4

—

Scoliosis

5.56

2.21

1.0

1.3

—

Visual disturbances and blindness

2.68

2.20

1.1

1.2

—

Pain in joint

2.81

2.18

1.0

1.2

—

Autoimmune diseases

2.03

2.17

1.2

—

General symptoms and signs

2.60

2.14

1.1

1.3

—

Osteopathies and chondropathies

3.32

2.14

1.6

1.2

—

Urticaria

2.78

2.13

1.3

1.2

—

Other acute lower respiratory infections

2.38

2.12

1.2

—

Persons encountering health services in circumstances related to reproduction

2.23

2.12

1.3

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.02

2.11

1.5

1.3

—

Anxiety (asthma-related co-morbidities)

2.81

2.09

1.5

1.3

—

Acute bronchitis

2.72

2.08

1.0

1.2

—

Viral infections characterized by skin and mucous membrane lesions

2.56

2.07

1.6

1.2

—

Glomerulonephritis

5.00

2.07

1.4

1.2

—

Unspecified acute lower respiratory infection

5.00

2.07

1.4

1.2

—

Disorders of speech understanding and production

3.15

2.05

1.1

1.3

—

Coagulation defects, purpura and other haemorrhagic conditions

4.00

2.04

1.3

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.07

2.01

1.4

1.2

—

Septicaemia

2.83

1.99

1.2

—

Hypopituitarism

3.34

1.96

1.4

1.2

—

Other neurological diseases

3.10

1.96

1.3

—

Mycoses

4.55

1.94

1.4

1.2

—

Candidiasis, including avohilmo

4.55

1.94

1.0

1.3

—

Exclusions for E4_PCOS_BROAD

2.73

1.92

1.3

1.2

—

Mood disorders, excluding more controls

3.13

1.90

1.4

1.3

—

Emotional disorders starting during childhood or adolecense, excluding more controls

4.41

1.89

1.4

1.1

—

Irregular menses

3.28

1.86

1.6

—

Contraceptive management

3.81

1.86

1.2

1.1

—

Symptoms and signs involving the digestive system and abdomen

2.05

1.84

1.3

1.2

—

Certain disorders involving the immune mechanism

4.17

1.82

1.0

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.12

1.82

1.4

1.2

—

Factors influencing health status and contact with health services

5.02

1.82

1.8

1.0

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.60

1.81

1.3

1.2

—

Other septicaemia

2.79

1.80

1.3

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

2.27

1.80

1.4

1.3

—

Acute upper respiratory infections

2.29

1.79

1.2

1.3

—

Other septicaemia, including avohilmo

2.78

1.79

1.3

1.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.76

1.79

1.3

1.2

—

Anomalies of dental arch relationship, including avohilmo

2.37

1.78

1.5

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

2.45

1.78

1.2

1.4

—

Infections of the skin and subcutaneous tissue

2.17

1.77

1.0

1.2

—

Open wound of head

2.35

1.76

1.2

—

Chromosomal abnormalities, not elsewhere classified

3.34

1.74

1.2

—

Other inflammation of eyelid, including avohilmo

2.50

1.73

1.1

1.5

—

ILD medications

1.98

1.73

1.3

1.2

—

Isolated growth hormone deficiency

3.90

1.72

1.4

1.2

—

Superficial injury of head

2.91

1.72

1.0

1.3

—

Covid-19 suspected case

3.85

1.71

1.4

1.3

—

Other diseases of blood and blood-forming organs, wide

3.85

1.71

2.4

1.2

—

Melanocytic naevi

3.85

1.71

1.0

1.3

—

Wide developmental disorders

2.91

1.71

1.0

1.3

—

Motor disorders

2.67

1.71

1.0

1.2

—

Congenital malformations of the circulatory system

2.27

1.66

1.3

1.2

—

Second line medication for Crohn's disease

2.50

1.66

1.3

1.2

—

L04AA Selective immunosuppressants

3.16

1.66

1.7

1.2

—

Other and unspecified urticaria

3.16

1.66

1.5

1.2

—

Other soft tissue disorders, not elsewhere classified

1.93

1.66

1.1

1.3

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2.19

1.65

1.4

1.3

—

Mental and behavioural disorders due to alcohol

3.66

1.64

1.6

1.3

—

Polycystic ovarian syndrome, consortium definition

2.70

1.62

1.5

—

Substance abuse

3.10

1.61

1.5

1.2

—

Otitis media, unspecified

2.54

1.61

1.1

1.2

—

Other diseases of pleura

3.62

1.60

1.0

1.3

—

Non-allergic asthma (mode), excluding more controls

3.54

1.60

1.8

1.2

—

Non-allergic asthma (mode)

3.54

1.60

1.8

1.2

—

Hyperkinetic disorders (excl. ADHD)

3.53

1.59

1.2

1.3

—

Migraine

2.36

1.58

1.3

1.2

—

Autoimmune diseases related-to ILD

2.32

1.57

1.4

1.3

—

Complications of procedures, not elsewhere classified

2.68

1.53

1.6

1.3

—

Cutaneous abscess, furuncle and carbuncle

3.33

1.52

1.0

1.3

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.89

1.51

1.2

—

Other obstetric conditions, not elsewhere classified

3.50

1.48

2.4

1.4

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.50

1.48

2.4

1.4

—

Dyspnoea

2.11

1.47

1.3

—

Short stature, not elsewhere classified

2.40

1.46

1.4

1.1

—

Disorders of refraction and accommodation

2.21

1.45

1.1

1.2

—

Conjunctivitis (acute, non atopic)

2.21

1.44

1.5

1.1

—

Inflammatory bowel disease

3.13

1.44

1.0

1.3

—

Migraine without aura

2.73

1.43

1.3

1.2

—

Haemorrhage from respiratory passages

3.16

1.43

1.6

1.1

—

Mental and behavioural disorders due to psychoactive substance use

2.75

1.43

1.5

1.2

—

2.02

1.40

1.3

1.2

—

Excessive, frequent and irregular menstruation

2.91

1.40

1.2

1.5

—

Cardiovascular diseases (excluding rheumatic etc)

1.81

1.40

1.4

1.2

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.67

1.40

1.3

1.2

—

Other arrhythmias

2.49

1.39

1.3

1.2

—

Mouth breathing

2.17

1.39

1.2

—

Other antidepressants

2.32

1.38

1.3

1.6

—

Other specific joint derangements/joint disorders

2.08

1.37

1.2

1.3

—

Suppurative and unspecified otitis media

2.21

1.37

1.2

—

General examination and investigation of persons without complaint and reported diagnosis

2.60

1.35

1.4

1.2

—

Depression or dysthymia

2.73

1.32

1.5

1.4

—

Diseases of the ear and mastoid process

1.95

1.31

1.4

1.3

—

Disorders of lipoprotein metabolism and other lipidaemias

3.04

1.30

2.6

1.1

—

Other disorders starting during childhood or adolescence

2.11

1.30

1.3

1.2

—

Opioids

2.43

1.29

1.3

1.5

—

Pain in limb

1.89

1.28

1.1

1.4

—

Disorders of sclera, cornea, iris and ciliary body

2.78

1.28

1.0

1.3

—

Deforming dorsopathies

2.78

1.28

1.0

1.2

—

Disorders of synovium and tendon

2.83

1.28

1.0

1.7

—

Diseases of the eye and adnexa

1.88

1.28

1.1

1.3

—

2.79

1.27

1.6

1.3

—

Exposure to unspecified factor

1.75

1.26

1.4

1.2

—

Abdominal and pelvic pain

1.83

1.26

1.2

—

Acute suppurative otitis media

2.26

1.25

1.3

1.2

—

Acute appendicitis

2.42

1.24

1.0

1.7

—

Dizziness and giddiness

2.45

1.24

1.3

1.4

—

Other strabismus

2.21

1.23

1.0

1.3

—

Disorders of skin appendages

2.21

1.23

1.3

1.2

—

Hypothyroidism, strict autoimmune

2.46

1.21

1.5

1.4

—

Acne

2.62

1.21

1.0

1.2

—

Hypothyroidism (congenital or acquired)

2.80

1.19

1.0

—

Appendicitis, broad definition

2.34

1.19

1.0

1.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2.02

1.19

1.1

1.2

—

Diseases of appendix

2.33

1.18

1.0

1.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.02

1.18

1.1

1.2

—

Cardiac murmurs and other cardiac sounds

2.28

1.17

1.2

—

Asthma, hospital admission 2, infections

1.86

1.14

1.3

1.2

—

Asthma-related infections

1.86

1.14

1.3

1.2

—

Acute appendicitis, no complications

2.48

1.14

1.0

1.5

—

Abnormalities of breathing

1.82

1.14

1.3

1.2

—

Other diseases of urinary system

1.87

1.14

1.2

1.3

—

Cystitis

2.05

1.12

1.1

1.3

—

L04AX Other immunosuppressants

2.00

1.11

1.4

1.2

—

Other bacterial diseases

1.83

1.11

1.3

1.2

—

Other medical care

2.47

1.11

1.6

1.1

—

Congenital malformations and deformations of the musculoskeletal system

1.99

1.11

1.0

1.3

—

Conjunctivitis

1.76

1.11

1.4

1.2

—

Pain in throat and chest

2.04

1.10

1.3

1.2

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.72

1.09

1.5

1.2

—

2.41

1.09

1.6

1.2

—

Heart failure, not strict

2.24

1.08

1.3

—

Sleep apnoea, including avohilmo

2.23

1.07

1.4

1.5

—

1.90

1.07

1.2

1.3

—

Persons encountering health services for examination and investigation

2.19

1.05

1.6

1.2

—

Concussion

1.99

1.05

1.3

1.2

—

Depression

1.97

1.04

1.3

1.4

—

Periapical abscess

2.27

1.03

1.2

—

Dentofacial anomalies [including malocclusion]

1.80

1.03

1.4

1.3

—

COPD/asthma related infections

2.00

1.02

1.3

1.2

—

COPD/asthma/ILD related infections

2.00

1.02

1.3

1.2

—

Certain infectious and parasitic diseases

1.75

1.00

1.2

—

Soft tissue disorders

1.62

0.99

1.2

1.3

—

Diseases of middle ear and mastoid

1.79

0.95

1.4

1.2

—

Congenital malformations of heart and great arteries

1.78

0.95

1.1

1.2

—

Disorders of eyelid, lacrimal system and orbit

1.78

0.94

1.1

1.3

—

Diabetes, varying definitions

1.78

0.94

1.6

1.3

—

Disorders of conjunctiva

1.67

0.94

1.6

1.2

—

Cardiovascular diseases

1.61

0.94

1.2

—

Mood [affective] disorders

1.88

0.93

1.4

—

Viral warts, including avohilmo

2.22

0.93

1.2

1.3

—

Diabetes mellitus

1.78

0.93

1.6

1.3

—

Mood disorders

1.88

0.93

1.4

—

Asthma (only as main-diagnosis)

2.03

0.92

1.4

1.1

—

Asthma (only as main-diagnosis), excluding more controls

2.01

0.92

1.4

1.1

—

Injuries to the wrist and hand

0.47

0.92

1.8

1.3

—

Other diseases of intestines

1.57

0.91

1.3

—

Diseases of the digestive system

2.13

0.91

1.3

1.2

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

1.89

0.88

1.0

1.2

—

Other disorders of ear

1.78

0.88

1.1

1.3

—

Fracture of lower leg, including ankle

2.03

0.88

1.5

1.2

—

Other nutritional deficiencies

1.87

0.87

1.5

1.3

—

Temporomandibular joint disorders, including avohilmo

2.00

0.87

1.2

1.5

—

Congenital malformations of cardiac septa

1.85

0.86

1.1

1.2

—

First line medication for Crohn's disease

1.59

0.86

1.3

1.2

—

Personal history of other diseases and conditions

1.99

0.86

1.5

1.2

—

Exposure to other specified factors

1.69

0.86

1.2

1.3

—

Strabismus

1.81

0.85

1.0

1.2

—

Acute bronchiolitis

1.81

0.85

1.0

1.2

—

COPD differential diagnosis

1.82

0.85

1.4

1.1

—

ILD differential diagnosis

1.82

0.85

1.4

1.1

—

Excluding asthma or asthma-COPD overlap

1.82

0.85

1.4

1.1

—

Other pulmonary diagnosis

1.82

0.85

1.4

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.00

0.77

0.0

1.1

—

Triptan medication for migraine, single purchase ok

1.69

0.75

1.0

1.4

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.69

0.75

1.0

1.4

—

Inflammatory diseases of female pelvic organs

2.14

0.75

1.0

1.8

—

Intracranial trauma

1.69

0.75

1.3

1.2

—

Unspecified fall

1.70

0.75

1.3

1.1

—

Asthma, unspecified (mode)

2.12

0.75

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.58

0.75

1.4

1.2

—

Asthma, unspecified (mode), excluding more controls

2.10

0.74

1.0

1.1

—

Other joint disorders

1.61

0.74

1.1

1.3

—

Urinary track infection

1.84

0.74

1.3

1.2

—

Necrosis of pulp, including avohilmo

2.06

0.74

1.0

1.5

—

Any reimbursement code in KELA

1.73

0.71

1.3

1.1

—

Gastrointestinal diseases

1.67

0.70

1.3

1.1

—

Other disorders of skin and subcutaneous tissue

1.92

0.70

1.4

1.2

—

Tooth eruption problems

1.69

0.69

1.0

1.2

—

Congenital malformations of genital organs

1.84

0.68

1.0

1.3

—

Asthma (mode)

1.67

0.67

1.4

1.1

—

Persons encountering health services in other circumstances, wide

1.53

0.66

1.2

—

Inflammatory bowel disease treatment related agents

1.52

0.66

1.3

—

Emotional disorders starting during childhood or adolescence

1.77

0.65

1.4

1.1

—

Cardiac arrhythmias

1.71

0.64

1.3

1.2

—

Complications of labour and delivery

0.00

0.63

0.0

1.6

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.00

0.63

0.0

1.3

—

Disorders of the thyroid gland

1.62

0.62

1.0

1.4

—

Dorsopathies

1.53

0.62

1.2

1.3

—

Pregnancy, childbirth and the puerperium

0.00

0.61

0.0

1.3

—

Insomnia

1.59

0.61

1.3

1.4

—

Pedal cyclist injured in transport accident

0.00

0.60

0.0

1.3

—

Nerve, nerve root and plexus disorders

1.80

0.60

1.2

1.6

—

Allergic colitis

0.00

0.59

0.0

1.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.53

0.59

1.8

1.2

—

Intracranial injury

1.52

0.58

1.0

1.2

—

Visual disturbances

1.67

0.56

1.2

—

Deep bite

1.46

0.56

1.3

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

1.48

0.55

1.4

1.2

—

Dermatitis due to ingested food

1.60

0.54

1.0

1.3

—

Caries of dentine, including avohilmo

0.59

0.54

1.3

—

Solid cancers, including Hilmo

1.59

0.54

1.5

1.4

—

Acne, including avohilmo

1.57

0.54

1.0

1.2

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.51

0.52

1.2

1.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.51

0.52

2.0

1.3

—

Persons with potential health hazards related to communicable diseases

1.42

0.51

1.0

1.2

—

Asthma

1.64

0.51

1.4

1.1

—

Asthma, excluding more controls

1.63

0.51

1.4

1.1

—

Neurological diseases, wide definition

1.60

0.50

1.4

1.2

—

Malignant neoplasm

1.58

0.50

1.7

1.3

—

Other bacterial diseases, including avohilmo

1.41

0.50

1.5

1.2

—

Falls/tendency to fall

1.38

0.49

1.3

—

Hypothyroidism, other/unspecified

1.53

0.49

1.4

1.5

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.53

0.49

1.4

1.5

—

Hard cardiovascular diseases

1.51

0.48

1.3

1.2

—

Noninfective enteritis and colitis

1.52

0.48

1.4

1.2

—

Arthropathies

1.43

0.47

1.1

1.3

—

Malignant neoplasm

1.46

0.47

1.7

1.3

—

Caries of enamel

1.43

0.46

1.4

1.2

—

Oral corticosteroids

1.41

0.45

2.0

1.4

—

Sleep apnoea

1.66

0.44

1.6

1.3

—

Crossbite

1.37

0.44

1.3

1.2

—

Malignant neoplasm, wide definition

1.45

0.43

1.6

1.4

—

Certain infectious and parasitic diseases, including avohilmo

1.43

0.43

1.4

1.1

—

Delivery, wide proxy

0.00

0.43

0.0

1.4

—

Single spontaneous delivery

0.00

0.43

0.0

1.4

—

Delivery

0.00

0.43

0.0

1.4

—

Conductive and sensorineural hearing loss

1.58

0.42

1.2

—

Heart failure, strict

0.00

0.42

0.0

1.3

—

Triptan medication for migraine, min. 3 purchases

1.56

0.42

1.0

1.6

—

Solid cancers

1.54

0.42

1.6

1.4

—

Contact with and exposure to communicable diseases

1.40

0.42

1.0

1.2

—

Polyarthropathies

1.53

0.41

1.2

1.4

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.41

0.0

1.2

—

Other fall from one level to another

1.51

0.41

1.2

1.3

—

Burns and corrosions of external body surface, specified by site

0.00

0.41

0.0

1.4

—

Coeliac disease

0.00

0.41

0.0

1.3

—

Burns and corrosions

0.00

0.41

0.0

1.4

—

Hernia of abdominal wall

0.00

0.41

0.0

1.3

—

Infections specific to the perinatal period

0.00

0.41

0.0

1.2

—

Percutaneous Coronary Intervention

1.35

0.41

1.4

1.2

—

Coronary revascularization (ANGIO or CABG)

1.35

0.41

1.4

1.2

—

Valvular heart disease excluding rheumatic fever

1.49

0.40

2.0

1.2

—

Emergency coronary revascularization (for ACS)

1.34

0.40

1.4

1.2

—

Other and unspecified effects of external causes

1.47

0.40

1.2

—

Other anxiety disorders

1.47

0.40

1.6

1.2

—

Other diseases of hard tissues of teeth

1.44

0.39

1.8

1.1

—

Diseases of oral cavity, salivary glands and jaws

1.43

0.39

1.6

1.1

—

Other congenital malformations

1.43

0.39

1.0

1.3

—

Asthma-related pneumonia

1.42

0.39

1.0

1.2

—

Asthma, hospital admissions 3, pneumonia

1.42

0.39

1.0

1.2

—

Asthma-related pneumonia or sepsis

1.42

0.39

1.0

1.2

—

Tumor necrosis factor alpha inhibitors

0.00

0.39

0.0

1.3

—

Other diseases of upper respiratory tract

0.69

0.39

1.5

1.2

—

Exclusions for E4_PCOS_CONSORTIUM

1.42

0.38

1.6

1.3

—

Diseases of the respiratory system

1.43

0.36

1.5

1.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

1.44

0.35

1.0

1.2

—

Insulin medication

1.42

0.35

2.0

1.3

—

Septal defects

1.37

0.34

1.2

—

Asthma, hospital admissions , main diagnosis only

1.35

0.34

1.4

1.2

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.38

0.34

1.5

1.3

—

Conjunctivitis (acute, non atopic), including avohilmo

0.66

0.34

1.2

1.1

—

Allergic conjunctivitis

1.31

0.33

1.2

1.4

—

Fall on same level

1.27

0.32

1.4

1.2

—

Injuries to the shoulder and upper arm

1.35

0.31

1.6

1.3

—

Parasetamol

1.31

0.31

1.3

1.4

—

Gingivitis and periodontal diseases

1.32

0.30

1.2

1.3

—

Diseases of pulp and periapical tissues, including avohilmo

0.73

0.30

1.0

1.3

—

Malignant neoplasm, including Hilmo

1.33

0.29

1.6

1.3

—

Major coronary heart disease event

1.33

0.29

1.4

1.2

—

Ischemic heart diseases

1.32

0.29

1.4

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

1.32

0.29

1.8

1.2

—

Sleep disorders

1.31

0.28

1.5

1.4

—

Other dorsopathies, not elsewhere classified

1.22

0.27

1.4

—

Mycoses, including avohilmo

1.22

0.27

1.3

1.4

—

Other heart diseases

1.21

0.27

1.6

1.2

—

Injuries to the head

1.26

0.26

1.0

1.3

—

Diseases of male genital organs

1.22

0.26

1.0

1.2

—

Other heart diseases, wide

1.27

0.26

1.4

1.3

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.34

0.23

1.6

1.5

—

Other congenital malformations, including avohilmo

1.32

0.23

1.0

1.2

—

Oxicams

0.00

0.22

0.0

1.8

—

Diverticular disease of intestine

0.00

0.22

0.0

1.3

—

Heart failure and antihypertensive medication

0.00

0.22

0.0

1.1

—

Non-ischemic cardiomyopathy

0.00

0.21

0.0

1.1

—

Tonsillectomy and adenotomy

0.77

0.21

1.4

1.3

—

Long labour

0.00

0.21

0.0

1.7

—

Heart failure,strict

0.00

0.21

0.0

1.3

—

Gonarthrosis [arthrosis of knee](FG)

0.00

0.21

0.0

1.9

—

Congenital deformities of feet, including avohilmo

0.00

0.21

0.0

1.5

—

Generalized epilepsy

0.00

0.21

0.0

1.4

—

Contact with heat and hot substances

0.00

0.21

0.0

1.3

—

Infectious mononucleosis, including avohilmo

0.00

0.21

0.0

1.2

—

Infectious mononucleosis

0.00

0.21

0.0

1.2

—

Otitis externa, unspecified

0.00

0.21

0.0

1.4

—

Bitten or struck by other mammals

0.00

0.21

0.0

1.3

—

Injury of eye and orbit

0.00

0.21

0.0

1.3

—

Chondropathies

0.00

0.21

0.0

1.4

—

Phobic anxiety disorders

0.00

0.21

0.0

1.1

—

Peritonsillar abscess

0.00

0.21

0.0

1.0

—

Umbilical hernia

0.00

0.21

0.0

1.1

—

Irritable bowel syndrome

0.00

0.21

0.0

1.4

—

Missing teeth due to accident, extraction or parodontitis

0.00

0.21

0.0

1.4

—

Other abnormal products of conception

0.00

0.21

0.0

2.0

—

Desensitization to allergens

0.00

0.21

0.0

1.3

—

Excessive earwax

1.16

0.21

1.0

1.2

—

Diseases of the skin and subcutaneous tissue

1.25

0.21

1.2

1.3

—

All-cause Heart Failure

0.00

0.20

0.0

1.3

—

Antihypertensive medication - note that there are other indications

1.25

0.20

1.4

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

1.26

0.20

1.0

1.4

—

Molar incisor enamel hypoplasia

1.19

0.19

1.3

1.2

—

Selective serotonin reuptake inhibitors

1.21

0.18

1.0

1.4

—

Dorsalgia

1.16

0.18

1.1

1.4

—

Injury, poisoning and certain other consequences of external causes

0.72

0.17

1.8

1.2

—

Atopic dermatitis, strict definition

1.12

0.17

2.0

1.1

—

Childhood allergy (age < 16)

0.76

0.17

1.4

1.1

—

Atopic dermatitis

0.78

0.16

1.8

1.2

—

Injuries to the ankle and foot

0.76

0.15

1.3

—

Benign neoplasms

1.21

0.14

1.3

1.4

—

Asthma, including avohilmo

0.85

0.13

1.4

1.3

—

Chronic diseases of tonsils and adenoids

1.18

0.12

1.4

1.2

—

Embedded and impacted teeth

1.10

0.09

1.0

1.2

—

Hypoplasia of dental enamel , including avohilmo

1.09

0.09

1.4

1.2

—

Crowding of teeth, including avohilmo

1.06

0.08

1.0

1.2

—

Finngen Rheumatological endpoints

1.10

0.08

1.1

1.5

—

Any event in cancer register

1.10

0.08

1.7

1.4

—

Allergic rhinitis

0.78

0.08

1.0

1.2

—

Other external causes of accidental injury

0.83

0.07

1.6

1.2

—

Accidents

0.83

0.07

1.6

1.2

—

Sleep disorders (combined)

1.04

0.07

1.4

1.3

—

Chronic lower respiratory diseases

0.92

0.05

1.5

1.2

—

Dermatitis and eczema

0.94

0.01

1.3

1.2

—

Neoplasms

0.98

0.00

1.5

1.2

—

Asthma/COPD (KELA code 203)

1.03

0.00

1.1

1.2

—

Injuries to the knee and lower leg

0.96

0.00

1.4

1.3

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.0

1.6

—

Open wound of ankle and foot

0.00

0.0

1.3

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.0

1.4

—

Diseases of pulp and periapical tissues and dental caries

0.94

0.00

1.7

1.1

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.0

1.6

—

Disorders of vitreous body and globe

0.00

0.0

1.3

—

Antenatal screening

0.00

0.0

1.0

—

Mesial bite

0.00

0.0

1.5

—

Slow fetal growth and fetal malnutrition

0.00

0.0

1.4

—

Meniscus derangement

0.00

0.0

1.8

—

Haemangioma and lymphangioma, any site

0.00

0.0

1.7

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.0

1.4

—

Congenital deformities of feet

0.00

0.0

1.5

—

Budesonide

0.00

0.0

1.4

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.0

1.6

—

Other symptoms and signs involving the digestive system and abdomen

0.00

0.0

1.3

—

Pneumococcal septicemia

0.00

-0.00

0.0

1.4

—

Other superficial mycoses, including avohilmo

0.00

-0.00

0.0

1.3

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

-0.00

0.0

1.5

—

Pediculosis, acariasis and other infestations

0.00

-0.00

0.0

1.6

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.91

-0.00

1.0

1.2

—

Other infections specific to the perinatal period

0.00

-0.00

0.0

1.2

—

Single delivery by forceps and vacuum extractor

0.00

-0.00

0.0

1.8

—

Ventral hernia

0.00

-0.00

0.0

1.2

—

Birth trauma

0.00

-0.00

0.0

1.6

—

Osteomyelitis

0.00

-0.00

0.0

1.1

—

Other shoulder lesions

0.00

-0.00

0.0

1.2

—

Need for immunization against single bacterial diseases

0.00

-0.00

0.0

1.6

—

Persistent mood disorders

0.00

-0.00

0.0

1.2

—

Obstructed labour due to malposition and malpresentation of fetus

0.00

-0.00

0.0

1.7

—

Torsion of testis

0.00

-0.00

0.0

1.3

—

Soft tissue disorders related to use, overuse and pressure

0.00

-0.00

0.0

1.2

—

Diseases of the musculoskeletal system and connective tissue

0.96

-0.00

1.6

1.3

—

Orchitis and epididymitis

0.00

-0.00

0.0

1.4

—

Other disorders of veins

0.00

-0.00

0.0

1.3

—

Foreign body in respiratory tract

0.00

-0.00

0.0

1.5

—

Injuries to the neck

0.00

-0.00

0.0

1.4

—

Hemiplegia

0.00

-0.00

0.0

1.6

—

Post-traumatic stress disorder

0.00

-0.00

0.0

1.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

-0.00

0.0

1.7

—

Juvenile osteochondrosis

0.00

-0.00

0.0

1.8

—

COPD, hospital admissions

0.00

-0.00

0.0

1.4

—

Coarctation of the aorta

0.00

-0.00

0.0

1.3

—

Injuries to the elbow and forearm

0.90

-0.00

1.2

—

Pain (limb, back, neck, head abdominally)

1.00

-0.00

1.3

1.2

—

Impacted maxillary molar

0.00

-0.00

0.0

1.6

—

Impacted maxillary canine

0.00

-0.00

0.0

1.3

—

Fissure and fistula of anal and rectal regions

0.00

-0.00

0.0

1.6

—

Atopic dermatitis, strict definition with reimbursement

0.87

-0.00

2.4

1.2

—

COPD, early/later onset

0.00

-0.00

0.0

1.4

—

Perineal laceration during delivery

0.00

-0.00

0.0

1.5

—

Crohn disease (strict definition, require KELA)

0.00

-0.00

0.0

1.7

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

-0.00

0.0

1.6

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

0.00

-0.00

0.0

1.4

—

Asthma (diagnoses ohter than nonallergic)

0.91

-0.00

1.1

1.3

—

Haemorrhoids and perianal venous thrombosis

0.00

-0.00

0.0

1.4

—

Dental caries, including avohilmo

0.94

-0.00

1.7

1.1

—

Hernia

0.92

-0.00

1.4

1.2

—

Heart failure and coronary heart disease

0.00

-0.00

0.0

1.0

—

Diabetes medication

0.88

-0.00

1.8

1.3

—

Prolonged pregnancy

0.00

-0.00

0.0

1.6

—

Varicose veins

0.00

-0.00

0.0

1.3

—

Lower back pain or/and sciatica

0.91

-0.00

1.2

1.5

—

Bacterial sepsis of newborn

0.00

-0.00

0.0

1.2

—

Perforation of tympanic membrane

0.00

-0.00

0.0

1.2

—

Mandibular prognathia

0.00

-0.00

0.0

1.6

—

Haemangioma, any site

0.00

-0.00

0.0

1.6

—

Disorders of vitreous body

0.00

-0.00

0.0

1.3

—

Ocular pain

0.00

-0.00

0.0

1.6

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

0.00

-0.00

0.0

1.6

—

Retinal detachments and breaks

0.00

-0.00

0.0

1.3

—

Viral pneumonia (known virus, not influenza)

0.00

-0.00

0.0

1.6

—

Other disorders of amniotic fluid and membranes

0.00

-0.00

0.0

1.5

—

Superficial injury of thorax

0.00

-0.00

0.0

1.7

—

Anorexia (incl.atypical)

0.00

-0.00

0.0

1.6

—

Other and unspecified injuries of head

0.00

-0.00

0.0

1.6

—

Injury of muscle and tendon at wrist and hand level

0.00

-0.00

0.0

1.4

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

-0.00

0.0

1.6

—

Injury of muscle and tendon at shoulder and upper arm level

0.00

-0.00

0.0

1.4

—

Effects of other external causes

0.00

-0.00

0.0

1.5

—

Foreign body on external eye

0.00

-0.00

0.0

1.6

—

Contact with other hot fluids

0.00

-0.00

0.0

1.3

—

Contact with sharp glass

0.00

-0.00

0.0

1.6

—

Dislocation, sprain and strain of joints and ligaments at neck level

0.00

-0.00

0.0

1.7

—

Contusion of ankle

0.00

-0.00

0.0

1.4

—

Glaucoma

0.00

-0.00

0.0

1.4

—

Superficial injury of hip and thigh

0.00

-0.00

0.0

1.5

—

Atopic conjunctivitis

0.00

-0.00

0.0

1.4

—

Pneumonia derived septicemia

0.00

-0.00

0.0

1.4

—

Voice disturbances

0.00

-0.00

0.0

1.4

—

Heartburn

0.00

-0.00

0.0

1.3

—

Burn and corrosion of wrist and hand

0.00

-0.00

0.0

1.7

—

Colonic or urogenital fistula

0.00

-0.00

0.0

1.6

—

External causes of morbidity and mortality

0.90

-0.00

1.6

1.2

—

Adalimumab

0.00

-0.00

0.0

1.6

—

Chronic periodontitis, complicated

0.00

-0.00

0.0

1.2

—

Acute lymphadenitis

0.00

-0.00

0.0

1.3

—

Foreign body entering into or through eye or natural orifice

0.00

-0.00

0.0

1.4

—

Overexertion and strenuous or repetitive movements

0.00

-0.00

0.0

1.6

—

Social phobias

0.00

-0.00

0.0

1.2

—

Hydrocephalus

0.00

-0.00

0.0

1.4

—

Car occupant injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.4

—

Contact with other sharp object(s)

0.00

-0.00

0.0

1.6

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

1.4

—

Other congenital malformations of face and neck

0.00

-0.00

0.0

1.4

—

Scabies

0.00

-0.00

0.0

1.6

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amino acids panel - Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS